Saxagliptin + metformin


( Last Updated : June 6, 2013)
Generic Name:
Saxagliptin + metformin
Project Status:
Withdrawn
Therapeutic Area:
Diabetes Mellitus, Type 2
Manufacturer:
Bristol-Myers Squibb / AstraZeneca Canada Inc.
Call for patient/clinician input open:
Brand Name:
Komboglyze
Project Line:
Reimbursement Review
Project Number:
SR0336-000
Call for patient/clinician input closed:

Details


Submission Type:
Initial
Indications:
Diabetes Mellitus, Type 2